CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals

BACKGROUND: Whether vexing clinical decision-making dilemmas can be partly addressed by recent advances in genomics is unclear. For example, when to initiate highly active antiretroviral therapy (HAART) during HIV-1 infection remains a clinical dilemma. This decision relies heavily on assessing AIDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Hemant, Agan, Brian K., Marconi, Vincent C., O'Connell, Robert J., Camargo, Jose F., He, Weijing, Delmar, Judith, Phelps, Kenneth R., Crawford, George, Clark, Robert A., Dolan, Matthew J., Ahuja, Sunil K.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2522281/
https://www.ncbi.nlm.nih.gov/pubmed/18776933
http://dx.doi.org/10.1371/journal.pone.0003165

Ejemplares similares

Ejemplares similares